BioIntelliSense

AirStrip Integrates BioIntelliSense Medical Wearable Devices and Data Services for Continuous Vital Sign Monitoring across Care Settings

Retrieved on: 
Tuesday, July 13, 2021
Technology, Medical devices, Hospitals, Other Technology, Software, Biotechnology, Internet, Health, Data management, Intensive care medicine, Medicine, Anesthesia, Monitoring, Nanomedicine, Health care, Health, AirStrip, BioIntelliSense, AIRSTRIP, BIOINTELLISENSE

AirStrip , a leading enterprise-grade platform for comprehensive medical data interoperability, analytics and mobile visualization, announced today that it has integrated the BioIntelliSense FDA-cleared BioSticker wearable medical device and medical grade BioButton health screening and status monitoring solution with its AirStrip ONE platform for in-hospital to home continuous wearable-enabled care.

Key Points: 
  • AirStrip , a leading enterprise-grade platform for comprehensive medical data interoperability, analytics and mobile visualization, announced today that it has integrated the BioIntelliSense FDA-cleared BioSticker wearable medical device and medical grade BioButton health screening and status monitoring solution with its AirStrip ONE platform for in-hospital to home continuous wearable-enabled care.
  • Together with BioIntelliSense, this high-resolution patient trending and personal baseline comparison enables actionable clinical decisions and proactive interventions across care settings.
  • AirStrip plays an integral role of bringing together BioIntelliSense continuous vital sign and physiologic data, along with other contextual insight, all in one place to optimize clinical workflow and deliver personalized clinical intelligence.
  • BioIntelliSense is ushering in a new era of continuous health monitoring and clinical intelligence for Remote Patient Monitoring (RPM).

ClearDATA and BioIntelliSense Combine Capabilities to Enhance Remote Patient Monitoring Platform Security and Compliance

Retrieved on: 
Thursday, May 6, 2021
Data management, Health, Security, Medical devices, Technology, Managed care, Software, Health informatics, Telehealth, Medical monitoring, As a service, Data as a service, Daas, Health, Remote patient monitoring, HITRUST, Medical record, Articles, BioIntelliSense, ClearDATA, BIOINTELLISENSE, CLEARDATA

The BioIntelliSense Data-as-a-Service (DaaS) platform remotely captures, stores and transmits encrypted patient data for advanced analytics in the BioCloud supported by ClearDATA safeguards for managing sensitive patient data (PHI/PII) with its HITRUST-certified SaaS platform and services backed by deep expertise in healthcare security and the cloud.

Key Points: 
  • The BioIntelliSense Data-as-a-Service (DaaS) platform remotely captures, stores and transmits encrypted patient data for advanced analytics in the BioCloud supported by ClearDATA safeguards for managing sensitive patient data (PHI/PII) with its HITRUST-certified SaaS platform and services backed by deep expertise in healthcare security and the cloud.
  • For more information on how BioIntelliSense is redefining remote patient monitoring through medical-grade and cost-effective data services, visit BioIntelliSense.com .\nBioIntelliSense is ushering in a new era of continuous health monitoring and clinical intelligence for Remote Patient Monitoring (RPM).
  • Its medical-grade Data-as-a-Service (DaaS) platform seamlessly captures minute-to-minute vital signs, physiological biometrics and symptomatic events through an effortless patient experience.
  • For more information, visit ClearDATA at www.cleardata.com .\nView source version on businesswire.com: https://www.businesswire.com/news/home/20210506005817/en/\n"

Lyniate Facilitates Interoperability Ecosystem via Strategic Partnerships

Retrieved on: 
Wednesday, June 3, 2020
Data management, Health, Technology, Hospitals, Practice Management, Other Health, Software, Interoperability, Product testing, Telecommunications engineering, Computing, Digital technology, Information and communications technology, Lyniate, BioIntelliSense, Healthcare Integration Consulting Group (HICG):

These companies are the latest to leverage Lyniates industry leading interoperability engines, Rhapsody and Corepoint , to streamline the complexities of healthcare data.

Key Points: 
  • These companies are the latest to leverage Lyniates industry leading interoperability engines, Rhapsody and Corepoint , to streamline the complexities of healthcare data.
  • Lyniate is a trusted partner and gives our hospitals the tools they need to solve the critical interoperability challenges of today while futureproofing against those of tomorrow.
  • About Lyniate: Lyniate partners with healthcare organizations around the globe delivering cutting-edge solutions to address interoperability challenges.
  • Lyniate is committed to delivering the best interoperability solutions for healthcare organizations, from specialty clinics to large networks, from payers to vendors, and everything in between.

ClinOne to Launch Breakthrough Continuous Patient COVID-19 Monitoring Solution Through Wearables Partnership with BioIntelliSense

Retrieved on: 
Tuesday, May 12, 2020
Infectious diseases, Health, Clinical trials, Medical devices, Health, Medicine, Clinical research, Pharmaceutical industry, Clinical pharmacology, Clinical trials, Design of experiments, Remote patient monitoring, Clinical monitoring, Monitoring, Virtual patient, Clinical trial portal, ClinOne, BioIntelliSense

ClinOne is expanding its strategic collaboration with BioIntelliSense to combine continuous health monitoring and clinical intelligence with the ClinOne ClinTrialConnect patient portal platform.

Key Points: 
  • ClinOne is expanding its strategic collaboration with BioIntelliSense to combine continuous health monitoring and clinical intelligence with the ClinOne ClinTrialConnect patient portal platform.
  • Our combined capabilities position ClinOne and BioIntelliSense to become the gold standard across all interventional clinical trials, according to Rob Bohacs.
  • The ClinOne solution and its suite of products were created to improve clinical trial enrollment, retention, virtual patient management and remote clinical monitoring.
  • BioIntelliSense is ushering in a new era of continuous health monitoring and clinical intelligence for Remote Patient Monitoring (RPM).